RHEA, a Recharge Capital women's healthcare strategy, is a growth-equity and private-equity crossover fund focused on IVF value-chain and menstrual wellness value-chain investments. The strategy seeks to obtain significant minority stakes and governance positions in modern women's healthcare companies and create ecosystem synergies across commercialization and distribution. The strategy differentiates itself through a large portion of proprietary opportunity creations in the forms of spin-offs, carve-outs, and incubating consolidations. The strategy is in partnership with NUS Singapore Lab, Thompson Medical and Hengrui Medicine for concrete operating value-adds. RHEA is one of Recharge Capital's strategies, a thematic-first asset manager that partners with operating businesses for industry-expertise and value creations.